Table 3 Demographic and biochemical data of cirrhotic patients with and without MHE.
Variable | Patients with MHE (n = 148) | Patients without MHE (n = 1517) | P value |
|---|---|---|---|
Age (years) | 56 (47.25, 62.75) | 52 (45, 61) | 0.008 |
Male gender, n (%) | 72 (48.65) | 1099 (72.45) | 0.000 |
Education (years) | 9 (6, 12) | 9 (9, 12) | 0.000 |
Aetiology of cirrhosis | Â | Â | 0.025 |
 Hepatitis B, n (%) | 117 (79.05) | 1329 (87.61) |  |
 Hepatitis C, n (%) | 12 (8.11) | 79 (5.21) |  |
 Autoimmune, n (%) | 14 (9.46) | 95 (6.26) |  |
Drug-induced liver injury, n (%) | 4 (2.70) | 14 (0.92) | Â |
Child–Pugh A/B/C, n (%) | 79 / 38 / 17 (58.96 / 28.36 / 12.69) | 1009 / 327 / 85 (71.01 / 23.01 / 5.98) | 0.002 |
Duration of cirrhosis (years) | 2 (1, 4) | 2 (1, 5) | 0.325 |
NCT-A raw score (second) | 121 (101.25, 171.25) | 59 (49, 72) | 0.000 |
DST raw score (point) | 20.5 (16, 24.75) | 42 (34, 50) | 0.000 |
Total bilirubin (umol/L) | 20.90 (12.80, 35.60) | 20.10 (13.80, 33.00) | 0.686 |
Albumin (g/L) | 37.02 ± 7.32 | 39.50 (33.20, 44.80) | 0.013 |
Platelets (*109/L) | 103.00 (63.75, 162.25) | 113.00 (69.00, 168.00) | 0.360 |
Prothrombin activity (%) | 80(63.5, 92) | 82 (65, 95) | 0.254 |
Ammonia (umol/L) | 31.65 (27.50, 49.75) | 35.00 (22.00, 52.75) | 0.716 |
Ascites at study inclusion, n (%) | 39 (36.11) | 283 (25.84) | 0.022 |
